HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: A large-scale, multicentre study

British Journal of Cancer

Volumn 109, Issue 6, 2013, Pages 1657-1665

  Attallah, A M ^a   Omran, M M ^b   Attallah, A A ^a   Abdallah, S O ^c   Farid, K ^d   Darwish, H ^e   El Dosoky, I ^d   Shaker, Y M ^f  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b Helwan University   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d MANSOURA UNIVERSITY   (Egypt)

^e Damietta Oncology Institute   (Egypt)

^f NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CHILD PUGH SCORE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HCC ART SCORE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84884592897     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.481     Document Type: Article

References (40)

1. Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, Asad S, Shahid I, Sumrin A, Khaliq S, Jahan S, Pervaiz A, Hassan S (2011) A comparison of four fibrosis indexes in chronic HCV: Development of new fibrosiscirrhosis index (FCI). BMC Gastroenterol 11: 44.
2. Alaboudy A, Inoue T, Hatanaka K, Chung H, Hyodo T, Kumano S, Murakami T, Moustafa EF, Kudo M (2011) Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoids- enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Oncology 81(Suppl 1): 66-72.
3. Anisimov VN (2007) Biology of aging and cancer. Cancer Control 14: 23-31.
4. Attallah AM, El-Far M, Abdel Malak CA, Zahran F, Farid K, Omran MM, Zagloul H, El-Deen MS (2011) Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma. Clin Chim Acta 412: 2310-2315.
5. Barreiros AP, Piscaglia F, Dietrich CF (2012) Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines. J Hepatol 57: 930-932.
6. Bialecki ES, Di Bisceglie AM (2005) Diagnosis of hepatocellular carcinoma. HPB (Oxford) 7: 26-34.
7. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatol 42: 1208-1236.
8. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. EASL Panel of Experts on HCC (2001) Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35: 421-430.
9. Camma C, Cabibbo GP (2009) Prognostic scores for hepatocellular carcinoma: None is the winner. Liver Int 2009 29: 478-480.
10. Castaldo G, Oriani G, Cimino L, Topa M, Budillon G, Salvatore F, Sacchetti L (1995) Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia. Clin Chem 41: 439-443.
11. Choi BI, Lee JM (2010) Advancement in HCC imaging: Diagnosis, staging and treatment efficacy assessments: Imaging diagnosis and staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 17: 369-373.
12. Cross TJ, Rizzi P, Berry PA, B ruce M, Portmann B, Harrison PM (2009) King's score: An accurate marker o f cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 21: 730-738.
13. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46: 2050-2068.
14. Franc AV, Valério HM, Trevisan M, Escanhoela C, Sevá-Pereira T, Zucoloto S, Martinelli A, Soares EC (2003) Fine needle aspiration biopsy improves the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytologica 47: 332-336.
15. Gonzalez SA, Keeffe EB (2011) Diagnosis of hepatocellular carcinoma: Role of tumor markers and liver biopsy. Clin Liver Dis 15: 297-306.
16. Goukassian D, Gad F, Yaar M, Eller MS, Nehal US, Gilchrest BA (2000) Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J 14: 1325-1334.
17. Gupta S, Bent S, Kohlwes J (2003) Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139: 46-50.
18. Hsieh YY, Tung SY, Lee IL, Lee K, Shen CH, Wei KL, Chang TS, Chuang CS, Wu CS, Lin YH (2009) FibroQ: An easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis. Chang Gung Med 32: 614-622.
19. Ishida H, Matsuo S, Inoue Y (2010) Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up. Rinsho Byor 58: 1065-1072.
20. Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T (2012) Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients. Am J Surg 203: 101-106.
21. Johnson PJ (2001) The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 5: 145-159.
22. Kashyap R, Jain A, Nalesnik M, Carr B, Barnes J, Vargas HE, Rakela J, Fung J (2001) Clinical significance of elevated alpha-fetoprotein in adults and children. Dig Dis Sci 46: 1709-1713.
23. Kew MC (2012) Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment. World J Hepatol 4: 99-104.
24. Koteish A, Thuluvath PJ (2002) Screening for hepatocellular carcinoma. J Vasc Interv Radiol 13: S185-S190.
25. Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Tanaka J, Yoshizawa H (2011) Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus. J Gastroenterol 46: 536-544.
26. Lai Q, Melandro F, Pinheiro RS, Donfrancesco A, Fadel BA, Levi Sandri GB, Rossi M, Berloco PB, Frattaroli FM (2012) Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: A brilliant star raises again. Int J Hepatol 2012: 893103.
27. Lehman EM, Wilson ML (2009) Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis. Int J Cancer 124: 690-697.
28. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Bru C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J (1998) Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power. Hepatol 27: 1572-1577.
29. Manichon AF, Bancel B, Durieux-Millon M, Ducerf C, Mabrut JY, Lepogam MA, Rode A (2012) Hepatocellular adenoma: Evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012: 418745.
30. Murakami T, Mochizuki K, Nakamura H (2001) Imaging evaluation of the cirrhotic liver. Semin Liver Dis 21: 213-224.
31. Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH (2000) Aspartate aminotransferases: Alanine aminotransferases ratio in chronic hepatitis C infection: Is it a predictor of cirrhosis? J Gastroenterol Hepatol 15: 386-390.
32. Patel M, Shariff MI, Ladep NG, Thillainayagam AV, Thomas HC, Khan SA, Taylor-Robinson SD (2012) Hepatocellular carcinoma: Diagnostics and screening. Eval Clin Pract 18: 335-342.
33. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349: 825-832.
34. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649.
35. Rothschild MA, Oratz M, Schreiber SS (1983) Effects of nutrition and alcohol on albumin synthesis. Alcohol Clin Exp Res 7: 28-30.
36. Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M (2009) Utility of Lens culinaris agglutininreactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 7: 104-113.
37. Tandon P, Garcia-Tsao G (2009) Prognostic indicators in hepatocellular carcinoma: A systematic review of 72 studies. Liver Int 29: 502-510.
38. The Cancer of the Liver Italian Program (CLIP) Investigators (2000) Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31: 840-845.
39. Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venin V, Fontaine H, Pol S (2007) FIB-4: An inexpensive and accurate marker of fibrosis in HC V infection. Comparison with liver biopsy and fibrotest. Hepatology 46: 32-36.
40. Yu MC, Chan KM, Lee CF, Lee YS, Eldeen FZ, Chou HS, Lee WC, Chen MF (2011) Alkaline phosphatase: Does it have a role in predicting hepatocellular carcinoma recurrence? J Gastrointest Surg 15: 1440-1449.